Literature DB >> 2477467

HIV-1 infection of first-trimester and term human placental tissue: a possible mode of maternal-fetal transmission.

W Maury1, B J Potts, A B Rabson.   

Abstract

To understand the potential role of placental tissue in the pathogenesis of neonatal AIDS, the distribution of human immunodeficiency virus type 1 (HIV-1) receptor and the infectability of placental tissue by HIV-1 were studied. Both the mRNA and the protein for the HIV receptor (CD4) were present in fetal-derived placenta. By immunofluorescent microscopy, a number of different cell types appeared to be CD4+; positive cells were observed in the lining and stroma of the chorionic villi. Some of these CD4+ cells dual-labeled with the trophoblastic marker placental lactogen. In addition, CD4+ cells were observed within the lining of placental blood vessels. Organ cultures of first-trimester and term placentas were infectable by HIV as monitored by reverse transcriptase activity of culture supernatants and by immunofluorescent labeling of HIV antigens. One potential route of congenital HIV transmission may be direct placental infection by HIV as early as the first trimester, with subsequent transplacental spread of the virus.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2477467     DOI: 10.1093/infdis/160.4.583

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  20 in total

1.  Immune-based approaches to the prevention of mother-to-child transmission of HIV-1: active and passive immunization.

Authors:  Barb Lohman-Payne; Jennifer Slyker; Sarah L Rowland-Jones
Journal:  Clin Perinatol       Date:  2010-12       Impact factor: 3.430

Review 2.  Role of the placenta in adverse perinatal outcomes among HIV-1 seropositive women.

Authors:  William Ackerman; Jesse J Kwiek
Journal:  J Nippon Med Sch       Date:  2013       Impact factor: 0.920

3.  Inhibition of murine embryonic growth by human immunodeficiency virus envelope protein and its prevention by vasoactive intestinal peptide and activity-dependent neurotrophic factor.

Authors:  D A Dibbern; G W Glazner; I Gozes; D E Brenneman; J M Hill
Journal:  J Clin Invest       Date:  1997-06-15       Impact factor: 14.808

4.  Human immunodeficiency virus type 1 infection of human placenta: potential route for fetal infection.

Authors:  N Amirhessami-Aghili; S A Spector
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

5.  Human trophoblast cells express CD4 and are permissive for productive infection with HIV-1.

Authors:  F J David; B Autran; H C Tran; E Menu; M Raphael; P Debre; B L Hsi; T G Wegman; F Barre-Sinoussi; G Chaouat
Journal:  Clin Exp Immunol       Date:  1992-04       Impact factor: 4.330

6.  Antibody-dependent cellular cytotoxicity and neutralizing activity in sera of HIV-1-infected mothers and their children.

Authors:  K Broliden; E Sievers; P A Tovo; V Moschese; G Scarlatti; P A Broliden; C Fundaro; P Rossi
Journal:  Clin Exp Immunol       Date:  1993-07       Impact factor: 4.330

7.  Identification of human immunodeficiency virus envelope gene sequences influencing viral entry into CD4-positive HeLa cells, T-leukemia cells, and macrophages.

Authors:  B Chesebro; J Nishio; S Perryman; A Cann; W O'Brien; I S Chen; K Wehrly
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

Review 8.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03

9.  Demonstration of HIV-1 infected cells in human placenta by in situ hybridisation and immunostaining.

Authors:  E Backé; E Jiménez; M Unger; A Schäfer; E Jauniaux; M Vogel
Journal:  J Clin Pathol       Date:  1992-10       Impact factor: 3.411

10.  Genetic analysis of human immunodeficiency virus type 1 envelope V3 region isolates from mothers and infants after perinatal transmission.

Authors:  N Ahmad; B M Baroudy; R C Baker; C Chappey
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.